Table 3.

Data by HBV vaccine response

	Control group			HIV-infected group
	Anti-HBs < 10	Anti-HBs ≥10	p-Value	Anti-HBs < 10	Anti-HBs ≥10	p-Value
	(n = 27)	(n = 85)		(n = 35)	(n = 14)
	m ± SD	m ± SD		m ± SD	m ± SD	m ± SD
Age (months)	64 ± 38	45 ± 35	0.991	59 ± 36	32 ± 26	0.998
Female	56%	37%	0.080	69%	50%	0.223
%T cells	67.5 ± 11.5	63.1 ± 9.0	0.986	75.7 ± 7.8	75.6 ± 5.9	0.652
%CD4+ T cells	34.1 ± 6.7	35.1 ± 7.0	0.741	23.6 ± 9.0	30.4 ± 8.4	0.008
%CD8+ T cells	27.4 ± 7.5	24.8 ± 7.6	0.963	46.0 ± 12.6	40.1 ± 9.2	0.928
%B cells	17.9 ± 9.5	21.6 ± 8.5	0.029	14.0 ± 7.0	16.7 ± 7.3	0.056
%NK cells	8.9 ± 5.0	09.1 ± 5.8	0.593	06.3 ± 3.1	04.3 ± 3.5	0.983
HAART	NA	NA	NA	65.71%	85.71%	0.185
HIV Viral load (log)	NA	NA	NA	2.4 ± 2.3	2.4 ± 2.1	0.5

m arithmetic mean, SD standard deviation, NA not applicable